HIV-tuberculosis coinfection in southern California: Evaluating disparities in disease burden

American Journal of Public Health

Volumn 100, Issue SUPPL. 1, 2010, Pages

  Rodwell, Timothy C ^a   Barnes, Richard F W ^a   Moore, Marisa ^a   Strathdee, Steffanie A ^a   Raich, Annie ^a   Moser, Kathleen S ^a   Garfein, Richard S ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; COST OF ILLNESS; HEALTH DISPARITY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SOCIAL CLASS; TUBERCULOSIS; UNITED STATES;

ADULT; AGED; CALIFORNIA; COMORBIDITY; COST OF ILLNESS; HEALTH STATUS DISPARITIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS; TUBERCULOSIS;

EID: 77950585601     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.170142     Document Type: Article

References (36)

1. 1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003 163(9): 1009-1021. (Pubitemid 36548927)
2. 2. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coin- fected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 200643(1): 42-46. (Pubitemid 44306486)
3. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol 2005;5(10): 819-826.
4. Valadas E, Antunes F. Tuberculosis, a re-emergent disease. Eur J Radiol 2005;55(2): 154-157.
5. Cantwell MF, Snider DE, Cauthen GM, Onorato IA. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994;272(7): 535-539.
6. Burwen DR, Bloch AB, Griffin LD, Ciesielski CA, Stern HA, Onorato IM. National trends in the concur-rence of tuberculosis and acquired- immunodefidency-syndrome. Arch Intern Med. 1995;155(12); 1281-1286.
7. Centers for Disease Control and Prevention. Trends in tuberculosis-United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(10): 249-253.
8. Marks S, Magee E, Robison V. Reported HIV status of tuberculosis patients-United States, 1993-2005. MMWR Morb Mortal Wkly Rep. 2007;56(42): 1103-1106.
9. San Diego Health and Human Service Agency (HHSA). Comparative Data: County of San Diego Tuberculosis Statistics, 2000-2007. Available at: http://www2.sdcounty.ca.gov/hhsa/documents/ fctshttables2007V2.pdf. Accessed January 14, 2009.
10. San Diego Health and Human Service Agency (HHSA). Tuberculosis Control Program 2006 Annual Report. Available at: http://www2.sdcounty.ca.gov/ hhsa/documents/AnnualReport2006-FINAL.pdf. Accessed January 10, 2009.
11. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10): 1-55.
12. Guidelines for Spedation Within the Mycobacterium tuberculosis Complex: WHO/EMC/ZOO/96.4. Geneva, Switzerland: World Health Organization; 1996.
13. San Diego Assodation of Governments (SANDAG). SANDAG Data Services. Available at: http://www. sandag.org/index.asp?fuseaction=home.data. Accessed January 14, 2009.
14. MeCullagh P, Neider JA. Generalized Linear Models. 2nd ed. London, England: Chapman Hall; 1989.
15. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. 2nd ed. Cary, NC: SAS Institute; 2000.
16. Hosmer DW, Lemeshow S. Applied Logistic Re-gression. New York, NY: John Wiley & Sons; 2000.
17. Pratt R, Robison V, Navin T, Menzies H. Trends in tuberculosis-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(11): 281-285.
18. Albalak R, O'Brien RJ, Kammerer JS, et al. Trends in tuberculosis/human immunodeficiency virus comorbid-ity, United States, 1993-2004. Arch Intern Med. 2007; 167(22): 2443-24 52.
19. Online Tuberculosis Information System (OTIS). National Tuberculosis Surveillance System, United States, 1993-2007. Available at: http://wonder.cdc.gov/ tb-v2007. Accessed March 6, 2009.
20. Porco TC, Small PM, Blower SM Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. J Acquir Immune Defic Syndr. 2001;28(5): 437-444.
21. San Diego Association of Governments (SANDAG). San Diego-Baja California, Land Ports of Entry: Fact Sheet Available at: http://www.sandag.cog.ca.us/ uploads/publicationid/publicationid-l184-5148.pdf. Accessed March 10, 2009.
22. Martinez-Donate AP, Rangei MG, Hoveil MF, Santibanez J, Sipan CL, Izazola JA. HIV infection in mobile populations: the case of Mexican migrants to the United States. Rev Panam Salud Publica. 2005;17(1): 26-29.
23. Schneider E, Laserson KF, Wells CD, Moore M. Tuberculosis along the United States-Mexico border, 1993-2001. Rev Panam Salud Publica. 2004;16(1): 23-34.
24. World Health Organization. 2008: Global Tuber-culosis Control-Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2008.
25. Laniado-Laborin R, Cabrales-Vargas N, Lopez-Espinoza G, Lepe-Zuniga JL, Quinonez-Moreno S, Rico-Vargas CE. Prevalence of tuberculosis infection in schoolchildren from Tijuana, Mexico. Salud Publica Mex. 1998;40(1): 47-52.
26. Perry KR, Ramskill S, Eglin RP, Barbara JAJ, Parry JV. Improvement in the performance of HIV screening kits. Transfus Med. 2008;18(4): 228-240.
27. Rangel MG, Martinez-Donate AP, Hovell MF, Santibanez J, Sipan CL, Izazola-Licea JA. Prevalence of risk factors for HIV infection among Mexican migrants and immigrants: probability survey in the North border of Mexico. Salud Publica Mex. 2006;48(1): 3-12.
28. Magis-Rodriguez C, Gayet C, Negroni M, et al. Migration and AIDS in Mexico-an overview based on recent evidence. J Acquir Immune Defic Syndr. 2004;37(suppl): S215-S226.
29. Organista KC, Carrillo M, Ayala G. HIV prevention with Mexican migrants-review, critique, and recom-mendations. J Acquir Immune Defic Syndr. 2004; 37(suppl):S227-S239.
30. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196(suppl 1): S86-S107.
31. Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2008;14(6): 909-916.
32. Sharma SK, Mohan A Multidrug-resistant tuber culosis-a menace that threatens to destabilize tubercu-losis control. Chest. 2006;130(1): 261-272.
33. Sterling TR, Zhao Z, Khan A, et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006; 10(5): 542-549.
34. Centers for Disease Control and Prevention. Reported HIV status of tuberculosis patients-United States, 1993-2005. MMWR Morb Mortal Wkly Rep. 2007;56(42): 1103-1106.
35. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8): 666-668.
36. Wong MD, Tagawa T, Hsieh HJ, Shapiro MF, Boscardin WJ, Ettner SL. Differences in cause-spedfic mortality between Latino and white adults. Med Care. 2005;43(10): 1058-1062.